Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GPR139 | Q6DWJ6 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26630479 | 1.00 | NLRP3 (0.48) | NLRP3TSHRSMN1; SMN2POLBGPR139 | |
| SCHEMBL26732715 | 0.89 | NLRP3 (0.47) | NLRP3TSHRGPR139 | |
| SCHEMBL29426614 | 0.89 | NLRP3 (0.47) | NLRP3TSHRGPR139 | |
| SCHEMBL26738768 | 0.89 | TSHR (0.46) | NLRP3TSHRSMN1; SMN2GPR139KMT2A | |
| SCHEMBL26732740 | 0.86 | NLRP3 (0.49) | NLRP3TSHRSMN1; SMN2GPR139KMT2A | |
| SCHEMBL26732714 | 0.84 | TSHR (0.50) | NLRP3TSHRSMN1; SMN2KMT2A | |
| SCHEMBL26739120 | 0.84 | TSHR (0.50) | NLRP3TSHRPOLBGPR139KMT2A | |
| SCHEMBL30450964 | 0.83 | NLRP3 (0.63) | NLRP3TSHRPOLB | |
| SCHEMBL30450966 | 0.83 | TSHR (0.49) | NLRP3TSHRSMN1; SMN2KMT2A | |
| SCHEMBL26738474 | 0.83 | TSHR (0.49) | NLRP3TSHRSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196125-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | Denali Therapeutics Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022036204-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | DENALI THERAPEUTICS INC. (US) | 2022-02-17 | — | — | WO | disclosed |